These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6713)

  • 1. The kinetics of enzyme action and inhibition in intact tissues and tissue slices, with special reference to cholinesterase.
    Green AL
    J Pharm Pharmacol; 1976 Apr; 28(4):265-74. PubMed ID: 6713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of cholinesterase hydrolysis of the substrate in the irreversible inhibition of the enzyme].
    Zhukovskiĭ IuG
    Izv Akad Nauk SSSR Biol; 1984; (1):55-61. PubMed ID: 6707315
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-cholinesterase action of a new organophosphorus ester, diethylphosphoric ester of the dicyclopropyloketoxime, on Wistar rats.
    Machera K; Kostakis E
    Bull Environ Contam Toxicol; 1992 Jan; 48(1):108-14. PubMed ID: 1581666
    [No Abstract]   [Full Text] [Related]  

  • 4. Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin.
    Harris LW; Fleisher JH; Clark J; Cliff WJ
    Science; 1966 Oct; 154(3747):404-7. PubMed ID: 5917091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholinesterases by complex derivatives of morphine.
    Lane AC; Macfarlane IR; McCoubrey A
    Biochem Pharmacol; 1966 Jan; 15(1):122-3. PubMed ID: 5939079
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxime reactivation of erythrocyte cholinesterase inhibited by ethyl p-nitrophenyl ethylphosphonate.
    Reiner E
    Biochem J; 1965 Dec; 97(3):710-4. PubMed ID: 5881660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphylated oximes. Some pharmaco-toxicological and biochemical features.
    Barstad JA; Lilleheil G; Skobba TJ
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):352-63. PubMed ID: 5367309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relations between chemical structure and cholinesterase-reactivating effect in a series of new asymmetric pyridinium salts. II. 2-hydroximino-methylpyridine derivates].
    Dirks E; Scherer A; Schmidt M; Zimmer G
    Arzneimittelforschung; 1970 Feb; 20(2):197-200. PubMed ID: 5467463
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of competitive and noncompetitive inhibition of cholinesterases of various origin].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Dokl Akad Nauk; 1999 Jan; 364(2):268-70. PubMed ID: 10188086
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of fluoride on cholinesterase. II. In vitro reactivation of cholinesterases inhibited by organophosphorous compounds.
    Heilbronn E
    Biochem Pharmacol; 1965 Sep; 14(9):1363-73. PubMed ID: 5857535
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of DFP and obidoxime on brain acetylcholine levels on brain and peripheral cholinesterases.
    Mayer O; Michalek H
    Biochem Pharmacol; 1971 Nov; 20(11):3029-37. PubMed ID: 4943596
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
    Chambers JE; Meek EC; Chambers HW
    Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the possible participation of metal complexes in the reactivation processes of cholinesterase inhibited by phosphoorganic compounds].
    Roginskaia EV; Shchekoldina VI
    Vopr Med Khim; 1966; 12(4):373-6. PubMed ID: 6000156
    [No Abstract]   [Full Text] [Related]  

  • 14. Strychnine as an anticholinesterase: in vitro studies with rat brain enzymes.
    Alid G; Valdés LF; Orrego FJ
    Experientia; 1974 Mar; 30(3):266-8. PubMed ID: 4824602
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estimation of anticholinesterase activity in reversible inhibitors of cholinesterase hydrolysis].
    Brestkin AP; Kuznetsova LP; Rozengart EV
    Ukr Biokhim Zh (1978); 1994; 66(1):66-72. PubMed ID: 7974841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators.
    Ashani Y; Bhattacharjee AK; Leader H; Saxena A; Doctor BP
    Biochem Pharmacol; 2003 Jul; 66(2):191-202. PubMed ID: 12826262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation and reactivation rates of fly and bee cholinesterases inhibited by sevin.
    Kunkee RE; Zweig G
    Biochem Pharmacol; 1965 Jun; 14(6):1011-7. PubMed ID: 5835867
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery of activity and molecular forms of cholinesterase in different animal species following irreversible cholinesterase inhibition.
    Mikalsen A; Andersen RA; Barstad JA; Lilleheil G
    Comp Biochem Physiol C Comp Pharmacol; 1982; 71C(1):27-35. PubMed ID: 6121668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative enzymology of catalytic properties of plasma cholinesterase in mink Mustela vison].
    Rozengart EV; Khovanskikh AE; Basova NE; Moralev SN
    Zh Evol Biokhim Fiziol; 2002; 38(4):311-5. PubMed ID: 12244675
    [No Abstract]   [Full Text] [Related]  

  • 20. N-(3,4,5-trimethoxyphenylethyl)-aziridine--a mescaline derivative: interaction with cholinesterases in vitro.
    Patocka J; Hrdina V; Zámocký J
    Act Nerv Super (Praha); 1989 Jun; 31(2):132-3. PubMed ID: 2800949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.